Venus Concept EBITDA

Que fait Venus Concept ? Venus Concept, Inc. generates revenue through its portfolio of medical aesthetic and hair restoration technologies, including Venus Versa, Venus Legacy, Venus Velocity, Venus Fiore, Venus Viva, Venus Freeze Plus, Venus Heal, Venus Skin, and Venus Bliss. The company sells these products to clinics and medical practices globally, operating in over 60 countries and 29 direct markets. Its hair restoration division features NeoGraft, an automated system for follicular unit extraction (FUE) procedures. Venus Viva combines NanoFractional Radio Frequency (RF) and SmartScan technology for facial, neck, and body treatments, while Venus Fiore targets vaginal health restoration with three specialized applicators. The company’s revenue streams include direct sales of devices and related practice enhancement services. Products like Venus Legacy and Venus Freeze Plus are marketed for non-invasive aesthetic procedures, while NeoGraft serves the hair restoration segment. Venus Fiore focuses on internal vaginal health, labia tightening, and mons pubis reduction, addressing niche medical needs. All offerings are distributed through the company’s global network, leveraging its presence in 29 direct markets. Venus Concept’s business model centers on selling minimally invasive and non-invasive medical aesthetic technologies to healthcare providers. The company’s product range spans multiple applications, from facial rejuvenation to hair restoration and intimate health. By maintaining a diverse portfolio under its branded products, Venus Concept ensures steady demand across various medical specialties and geographic regions. Venus Concept est l'une des entreprises les plus populaires sur Eulerpool.